Bihar to be the next Medical Tourism Hub says Paras Hospital & UK Asian Business Council

IMT News Desk
IMT News Desk
· 3 min read

With a strategic view to tap the foreign tourist inflow in Bihar for medical tourism purpose, the UK Asian Business Council (UKABC) conducted an event on behalf of Paras Healthcare to take tourism in Bihar to a higher level and highlighted the need for state government and Paras to work together to make that happen. Paras opened the first super specialty hospital in Gaya and another one in Patna.

Dr Sarfraz Ashraf, Vice President-UKABC and an associate of the Executive Management of Paras Hospitals, said that the private healthcare provider has been in Bihar for 10 years and is committed to serve the people of the state in a larger capacity and scale.

He highlighted to the Tourism Minister of Bihar, Pramod Kumar, along with his senior colleagues in the ministry who were present, the need for a super specialty hospital in Gaya which sees a steady flow of foreign tourists and is home to people who may require these medical services.

“On behalf of Paras and UKABC, I would propose that a super specialty hospital be considered for Gaya. Attractive to tourists and home to diverse people, we hope to facilitate good health to those who come for spiritual and religious healing. The UKABC considers it important that the Bihar government gives us the opportunity to work with them and rebrand the kind of tourism that comes to Bihar,” he said. Dr Ashraf has been actively working for greater participation and coordination between Indian and British businesses.

He also spoke about how Paras provides affordable healthcare to masses with latest technology and makes a difference to the lives of the people in Bihar. Director of Tourism in Bihar, Ashok Singh was also present in the event.

Pramod Kumar assured of support from the state government to Paras and spoke about the possibility of Bihar becoming an important centre for medical tourism for people in foreign countries like Sri Lanka, Korea, Japan, Taiwan, Thailand, Myanmar and Bhutan.

Ruth Cadbury, Member Of Parliament, admired the work done by Paras in the state. Miss Dame Usha Khemka, only the fourth Indian woman to be knighted by the Queen of England, spoke on the need to bring about change on the ground in Bihar. She hails from Bihar.

UKABC Chairman Taha Coburn-Kutay, UKABC President Mr Junaid Ahmed, UKABC (Europe) Vice President Mr Sudeep Sakalle were also present at the event.

According to Dr Dharminder Nagar, “Paras Healthcare is always focused on providing affordable, accessible and quality healthcare services to the common man. It shall be our honour to associate with the Bihar Tourism ministry and ensure that Bihar comes up as the next medical tourism destination. The state has exceptional untapped talent, resources and history that needs appreciation.”

Read Next

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk